Hépato-Gastro & Oncologie Digestive
Volume 29, supplement 4, August 2022
News from JFHOD 2022: Focus on immunotherapy in digestive cancers
Numéro réalisé avec le soutien institutionnel des laboratoires MSD et AstraZeneca
Volume 29, supplement 4, August 2022
Synthèse des communications
News in the management of oesogastric cancers
(p.5-12)
David Sefrioui
Managment of hepatobiliary cancers
(p.13-20)
Yann Touchefeu, Juliette Boilève
Current Knowledge on immunotherapy in digestive cancers (excluding HCC and biliary tract) at the time of the JFHOD 2022
(p.21-30)
Jean-Marc Phelip, Quentin Tournier, Nicolas Williet